Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

about

Infliximab for ipilimumab-induced colitis: A series of 13 patients.Central hypothyroidism - a neglected thyroid disorder.Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma.

P2860

Q39040949-3BCCDBB6-76F5-40FF-A833-A8B09C3B4A2C Q39332895-6D43BB81-6D81-47B1-811B-289B08C07CAD Q51307035-86BF1C0F-8937-467E-8346-AD4A404504EB

P2860

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

Item

http://www.wikidata.org/entity/Q38502692

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

@en

type

Item

label

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

@en

prefLabel

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

@en

P1476

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

@en

P2093

A Clements

http://www.w3.org/2001/XMLSchema#string

A N Sweeting

http://www.w3.org/2001/XMLSchema#string

D R Chipps

http://www.w3.org/2001/XMLSchema#string

E Chua

http://www.w3.org/2001/XMLSchema#string

K Tonks

http://www.w3.org/2001/XMLSchema#string

M M K Chan

http://www.w3.org/2001/XMLSchema#string

M S Carlino

http://www.w3.org/2001/XMLSchema#string

T Lam

http://www.w3.org/2001/XMLSchema#string

P2860

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The emerging role of the CTLA-4 gene in autoimmune endocrinopathies

Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.

Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease

Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.

P304

1066-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMJ.12819

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Georgina V. Long

Richard F. Kefford

Sunita M C De Sousa

P577

2015-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26010858

http://www.w3.org/2001/XMLSchema#string

P921

Ipilimumaab

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

about

P2860

P2860

Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921